Incyte | Eigenkapital Und Reserven





Eigenkapital Und Reserven Veränderung Datum
Acadia Pharmaceuticals USD 917.27M 94.89M 2025-09
Agenus USD -274.14M 80.46M 2025-09
Agios Pharmaceuticals USD 1.19B 91.22M 2025-12
Alnylam Pharmaceuticals USD 789.18M 555.28M 2025-12
Amgen USD 8.66B 961M 2025-12
BioCryst Pharmaceuticals USD -387.89M 33.7M 2025-09
Biogen USD 18.21B 573.5M 2025-09
BioMarin Pharmaceutical USD 6.06B 29.6M 2025-09
Bristol-Myers Squibb USD 18.55B 1.06B 2025-09
Eli Lilly USD 26.54B 2.74B 2025-12
Exelixis USD 2.16B 619K 2025-12
Gilead Sciences USD 22.62B 1.16B 2025-12
Incyte USD 5.17B 516.28M 2025-12
Ionis Pharmaceuticals USD 617.97M 13.76M 2025-09
MacroGenics USD 67M 20.38M 2025-09
Merck USD 51.85B 2.79B 2025-09
Moderna USD 8.65B 680M 2025-12
Nektar Therapeutics USD 85.09M 109.3M 2025-09
Neurocrine Biosciences USD 3.25B 249.5M 2025-12
Novartis USD 44.75B 2.7B 2025-09
Novartis USD 44.33B 2.28B 2025-09
Pfizer USD 92.8B 4.11B 2025-09
PTC Therapeutics USD -155.76M 50.79M 2025-09
Puma Biotechnology USD 115.27M 10.55M 2025-09
Regeneron Pharmaceuticals USD 31.26B 299.1M 2025-12
Sarepta Therapeutics USD 1.32B 37.26M 2025-09
Ultragenyx Pharmaceutical USD 9.16M 142.13M 2025-09
Vertex Pharmaceuticals USD 18.67B 1.35B 2025-12


Incyte Eigenkapital Und Reserven - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.